(CNN) - About one in eight adults said they have taken a GLP-1 drug like Ozempic or Mounjaro, according to a new poll from ...
These drugs can be costly, with list prices topping $1,000 for a month’s supply before insurance coverage, rebates and ...
Health-care companies rose as optimism about a boom in obesity drugs regained momentum. Novo Nordisk shares ticked up after the maker of obesity ...
BURLINGTON, Vt. (WCAX) - Vermont Green FC will host a women’s exhibition match against FC Laval of Quebec’s Ligue 1 on June 22nd, with former USWNT star Sam Mewis and UVM women’s soccer head ...
(WCAX) - Vermont Senator Bernie Sanders this week launched an investigation into the pricing of Ozempic and Wegovy, two drugs that are highly effective at treating diabetes and obesity, but now ...
In fact, analysts say the obesity drug market is about to get a lot more crowded, with more than a dozen new therapies poised to launch by decade’s end. These span both new combination injectable ...
Sen. Bernie Sanders (I-Vt.), chair of the Senate Health, Education, Labor, and Pensions (HELP) Committee, launched an ...
Add headaches, swelling of nasal passages, allergic reactions, pancreatitis, and fatigue to the list, along with rare cases ... Semaglutides are a powerful class of drugs helping push back on the ...
As GLP-1 agonist, it is among the class of drugs that have until recently only been approved to treat diabetes and obesity. Medicare is prohibited from covering weight loss medications due to the ...
As GLP-1 agonist, it is among the class of drugs that have until recently only been approved to treat diabetes and obesity. Medicare is prohibited from covering weight loss medications due to the ...
As GLP-1 agonist, it is among the class of drugs that have until recently only been approved to treat diabetes and obesity. Medicare is prohibited from covering weight loss medications due to the ...